Cryoablation effective in women with breast cancer
A minimally invasive procedure called cryoablation that uses ice to freeze and destroy tumors has proven effective for women with large breast cancer tumors, according to a study presented March 27 at the Society of Interventional Radiology (SIR) meeting in Salt Lake City.
The finding suggests the technique may provide a new treatment path for women who are not candidates for lumpectomy, or surgical removal, noted Yolanda Bryce, MD, an interventional radiologist at Memorial Sloan Kettering Cancer Center in New York City, and senior author of the study.
“Surgery is still the best option for tumor removal, but there are ...
Source: AuntMinnie.com Headlines - March 27, 2024 Category: Radiology Authors: Will Morton Tags: Interventional Breast Source Type: news
Big Drop in Rate of Ipsilateral Breast Cancer After DCIS
(MedPage Today) -- The incidence of invasive breast cancer after conservative treatment for ductal carcinoma in situ (DCIS) decreased by more than 50% over the past 30 years, data from a Dutch cancer registry showed.
Among 19,000 patients who... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 26, 2024 Category: Hematology Source Type: news
CT shows effects of sarcopenia on liver cancer survival
CT has revealed that sarcopenia is a prognostic factor for poor overall survival after liver resection for cancer, researchers have reported.
Five-year overall survival was significantly lower in sarcopenic patients than in those without the condition, at 58.2% and 83.6%, respectively, a team led by Thanatchawan Polvieng, MD, of Phramongkutklao Hospital in Bangkok, Thailand, reported. The results were published March 22 in American Surgeon.
"Major postoperative complications were more frequent in sarcopenia," the group noted.
Polvieng and colleagues conducted a study that explored the prognostic impact of sarcopenia (i....
Source: AuntMinnie.com Headlines - March 22, 2024 Category: Radiology Authors: Kate Madden Yee Tags: CT Abdominal Imaging Source Type: news
Sarcopenia May Predict FT Placement in Patients With OPSCC Sarcopenia May Predict FT Placement in Patients With OPSCC
Identifying sarcopenia early in patients with oropharyngeal squamous cell carcinoma can help predict the need for feeding tube placement.Medscape Medical News (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - March 22, 2024 Category: Pathology Tags: Hematology-Oncology Source Type: news
Sarcopenia Predicts Feeding Tube Placement in OPSCC Patients Sarcopenia Predicts Feeding Tube Placement in OPSCC Patients
Identifying sarcopenia early in patients with oropharyngeal squamous cell carcinoma can help predict the need for feeding tube placement.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 22, 2024 Category: Consumer Health News Tags: Hematology-Oncology Source Type: news
De-escalating Therapy for Oropharynx Squamous Cell Carcinoma De-escalating Therapy for Oropharynx Squamous Cell Carcinoma
Three new studies exploring treatment de-escalation of HPV-associated oropharynx squamous cell carcinoma added to data showing it ' s possible to reduce toxicity without jeopardizing oncologic outcomes.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 19, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
She beat a rare liver cancer – and now works with her father to find more cures
Cancer scientist decides to study the tumour that once afflicted his small daughter – and now her work is adding to his project’s successElana Simon was 10 years old when she started to experience severe pains in her abdomen. For two years, puzzled doctors put forward diagnoses including lactose intolerance, Crohn ’s disease and stress. It was not until 2008 that they pinpointed the real cause. Elana was suffering from fibrolamellar carcinoma(FLC), a rare, usually lethal, form of liver cancer.“In a way, it was comforting to have a word for what was wrong with me after so much confusion about my condition,” Elana ...
Source: Guardian Unlimited Science - March 16, 2024 Category: Science Authors: Robin McKie Science Editor Tags: Cancer research Medical research Science UK news Source Type: news
New PD-1 Inhibitor Approved for Esophageal Cancer
(MedPage Today) -- The FDA approved tislelizumab (Tevimbra) for advanced/metastatic esophageal squamous cell carcinoma (ESCC) previously treated with chemotherapy, BeiGene announced.
The approval stipulates use of the PD-1 inhibitor in adults... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - March 15, 2024 Category: American Health Source Type: news
FAPI-PET/CT outperforms FDG-PET/CT in women with invasive breast cancer
This study underscores Ga-68 FAPI-PET/CT’s superiority over F-18 FDG-PET/CT for ILC,” the group concluded. A link to the full study can be found here. (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 15, 2024 Category: Radiology Authors: Will Morton Tags: Breast Source Type: news
FDA Approves New Esophageal Cancer Drug FDA Approves New Esophageal Cancer Drug
The checkpoint inhibitor is approved for second-line treatment of patients with esophageal squamous cell carcinoma after prior systemic chemotherapy that did not include a PD-L1 inhibitor.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 15, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
FDA Approves Tevimbra (tislelizumab-jsgr) for the Treatment of Advanced or Metastatic Esophageal Squamous Cell Carcinoma
BASEL, Switzerland& BEIJING& CAMBRIDGE, Mass.--(BUSINESS WIRE)-- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has approved... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - March 14, 2024 Category: Drugs & Pharmacology Source Type: news
Imaging surveillance suggested for radial scars found on DBT
Imaging surveillance may be the way to go for monitoring radial scars without atypia found on screening digital breast tomosynthesis (DBT), research published March 13 in the American Journal of Roentgenology found.
In a study, Claire Crowley and Manisha Bahl, MD, from Massachusetts General Hospital in Boston, found that screening-detected radial scars without atypia at core-needle biopsy have a low upstaging rate to breast cancer of less than 2%.
“Our results, which show that surgical excision is not necessary for all patients with radial scars, could lead to a reduction in unnecessary surgery and could save patients ...
Source: AuntMinnie.com Headlines - March 14, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Subspecialties Womens Imaging Breast Breast Imaging Source Type: news
Beta-defensin index: A functional biomarker for oral cancer detection
Cell Reports Mediine AccessPublished:March 04, 2024DOI:https://doi.org/10.1016/j.xcrm.2024.101447SummaryThere is an unmet clinical need for a non-invasive and cost-effective test for oral squamous cell carcinoma (OSCC) that informs clinicians when a biopsy is warranted. Human beta-defensin 3 (hBD-3), an epithelial cell-derived anti-microbial peptide, is pro-tumorigenic and overexpressed in early-stage OSCC compared to hBD-2. We validate this expression dichotomy in carcinoma in situ and OSCC lesions using immunofluorescence microscopy and flow cytometry. The proportion of hBD-3/hBD-2 levels in non-invasivel...
Source: Dental Technology Blog - March 12, 2024 Category: Dentistry Source Type: news
ARRS announces Resident/Fellow in Radiology awardees
The American Roentgen Ray Society (ARRS) is recognizing four radiologists, as well as their institutions and research projects, with its 2024 ARRS Resident/Fellow in Radiology Awards.
The following radiologists and their research projects are recognized as awardees:
ul.editorialList li {margin-bottom:6px;}
Melina Hosseiny, MD, University of California, San Diego. ARRS President’s Award for “Multi-task Ensemble Deep Learning for Differential Diagnosis of Pneumonia and Pulmonary Edema on Chest Radiograph.”
Ahmed Taher, MD, University of Texas Health Science Center at Houston. ARRS Executive Council Award for “...
Source: AuntMinnie.com Headlines - March 12, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: People in the News Source Type: news
Does breast radiation therapy raise risk of skin cancer?
Radiation therapy for breast cancer treatment leads to an increased risk of skin cancer, according to research published March 8 in JAMA Network Open.
A team led by Shawheen Rezaei from Stanford University found that the risk of non-keratinocyte skin cancer diagnosis such as melanoma and hemangiosarcoma after breast cancer treatment with radiation was more than 50% higher.
“Although occurrences of non-keratinocyte skin cancers are rare, physicians should be aware of this elevated risk to help inform follow-up care,” the Rezaei team wrote.
While breast cancer treatment strategies have improved over the decades, survi...
Source: AuntMinnie.com Headlines - March 11, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Subspecialties Womens Imaging Breast Breast Imaging Source Type: news
